258 related articles for article (PubMed ID: 23190091)
1. Predictive scoring model of mortality in Gram-negative bloodstream infection.
Al-Hasan MN; Lahr BD; Eckel-Passow JE; Baddour LM
Clin Microbiol Infect; 2013 Oct; 19(10):948-54. PubMed ID: 23190091
[TBL] [Abstract][Full Text] [Related]
2. Mortality associated with bloodstream infection after coronary artery bypass surgery.
Olsen MA; Krauss M; Agniel D; Schootman M; Gentry CN; Yan Y; Damiano RJ; Fraser VJ
Clin Infect Dis; 2008 May; 46(10):1537-46. PubMed ID: 18419488
[TBL] [Abstract][Full Text] [Related]
3. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis.
Cain SE; Kohn J; Bookstaver PB; Albrecht H; Al-Hasan MN
Antimicrob Agents Chemother; 2015 Jan; 59(1):245-50. PubMed ID: 25348527
[TBL] [Abstract][Full Text] [Related]
4. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection.
Battle SE; Augustine MR; Watson CM; Bookstaver PB; Kohn J; Owens WB; Baddour LM; Al-Hasan MN
Infection; 2019 Aug; 47(4):571-578. PubMed ID: 30737765
[TBL] [Abstract][Full Text] [Related]
5. The impact of previous hospitalization in the preceding 90 days on the outcome in critically ill patients with gram-negative bloodstream infection.
Zeng Q; Xu F; Jiang S
Diagn Microbiol Infect Dis; 2014 Oct; 80(2):136-40. PubMed ID: 25128476
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of early clinical failure criteria for gram-negative bloodstream infections.
Rac H; Gould AP; Bookstaver PB; Justo JA; Kohn J; Al-Hasan MN
Clin Microbiol Infect; 2020 Jan; 26(1):73-77. PubMed ID: 31158519
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of bloodstream infections in burn patients: An 11-year retrospective study.
Patel BM; Paratz JD; Mallet A; Lipman J; Rudd M; Muller MJ; Paterson DL; Roberts JA
Burns; 2012 Aug; 38(5):685-90. PubMed ID: 22348799
[TBL] [Abstract][Full Text] [Related]
8. External validation of bloodstream infection mortality risk score in a population-based cohort.
Al-Hasan MN; Juhn YJ; Bang DW; Yang HJ; Baddour LM
Clin Microbiol Infect; 2014 Sep; 20(9):886-91. PubMed ID: 25455590
[TBL] [Abstract][Full Text] [Related]
9. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis.
Battle SE; Bookstaver PB; Justo JA; Kohn J; Albrecht H; Al-Hasan MN
J Antimicrob Chemother; 2017 Jan; 72(1):299-304. PubMed ID: 27986899
[TBL] [Abstract][Full Text] [Related]
10. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
[TBL] [Abstract][Full Text] [Related]
11. Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization.
Brigmon MM; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Clin Microbiol Infect; 2015 Sep; 21(9):843-9. PubMed ID: 26003282
[TBL] [Abstract][Full Text] [Related]
12. Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality.
Rojas L; Muñoz P; Kestler M; Arroyo D; Guembe M; Rodríguez-Créixems M; Verde E; Bouza E
J Hosp Infect; 2013 Nov; 85(3):196-205. PubMed ID: 24001997
[TBL] [Abstract][Full Text] [Related]
13. Effect of cefepime dose on mortality of patients with Gram-negative bacterial bloodstream infections: a prospective cohort study.
Alves MD; Ribeiro VB; Tessari JP; Mattiello F; De Bacco G; Luz DI; Vieira FJ; Behle TF; Pasqualotto AC; Zavascki AP
J Antimicrob Chemother; 2014 Jun; 69(6):1681-7. PubMed ID: 24474430
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.
Dan S; Shah A; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2265-72. PubMed ID: 26833166
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis.
Bartoletti M; Giannella M; Caraceni P; Domenicali M; Ambretti S; Tedeschi S; Verucchi G; Badia L; Lewis RE; Bernardi M; Viale P
J Hepatol; 2014 Jul; 61(1):51-8. PubMed ID: 24681345
[TBL] [Abstract][Full Text] [Related]
16. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients.
Gudiol C; Bodro M; Simonetti A; Tubau F; González-Barca E; Cisnal M; Domingo-Domenech E; Jiménez L; Carratalà J
Clin Microbiol Infect; 2013 May; 19(5):474-9. PubMed ID: 22524597
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis.
Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Int J Antimicrob Agents; 2018 Mar; 51(3):488-492. PubMed ID: 28919195
[TBL] [Abstract][Full Text] [Related]
18. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
[TBL] [Abstract][Full Text] [Related]
19. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
Peralta G; Sánchez MB; Garrido JC; De Benito I; Cano ME; Martínez-Martínez L; Roiz MP
J Antimicrob Chemother; 2007 Oct; 60(4):855-63. PubMed ID: 17644532
[TBL] [Abstract][Full Text] [Related]
20. Value of the Pitt Bacteraemia Score to predict short-term mortality in Staphylococcus aureus bloodstream infection: a validation study.
Roth JA; Tschudin-Sutter S; Dangel M; Frei R; Battegay M; Widmer AF
Swiss Med Wkly; 2017; 147():w14482. PubMed ID: 28804865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
